Investigation of P-glycoprotein transport cycle using molecular dynamics as an approach to reduce anti-cancer drug resistance

by Shubbar, A.; Moradi, M.

Drug resistance to chemotherapeutic drugs is a very challenging problem that often results in clinical failure of highly effective medications. A major mechanism of drug resistance can be attributed to the multi-drug resistance transporters that efflux drugs from the cytosol to the extracellular space. P-glycoprotein (P-gp) is a transmembrane ABC transporter that plays a crucial role in the reduction of intracellular concentration of a diverse range of xenobiotics that can vary tremendously in net charge, molecular size, and physicochemical properties. P-gp consists of two symmetrical nucleotide binding domains that utilize ATP hydrolysis to undergo a conformational change from the inward state to the outward state. This conformational change is typically induced by the binding of the substrate or the drug and thereby reduces the effective intracellular concentration of anti-cancer drugs. This study aims to utilize molecular dynamics (MD) simulations to understand the local and global conformational changes of the inward and outward states of a high-resolution crystal structure of the eukaryotic P-gp in a POPC bilayer. Another objective of this study was to biosimulate the newly solved cryoEM structures of human P-gp, which was important as the vast majority of MD studies have been performed on either murine P-gp or on only the homology models of human P-gp. Several computational simulations have been performed to get a better understanding of P-gp transport cycle. The utilization of both equilibrium and non-equilibrium MD simulations has enabled us to further elucidate how P-gp transitions between inward and outward states in eukaryotes in general and human in particular.